Stay updated on Olaparib in Metastatic Prostate Cancer (PROfound Study) Clinical Trial
Sign up to get notified when there's something new on the Olaparib in Metastatic Prostate Cancer (PROfound Study) Clinical Trial page.

Latest updates to the Olaparib in Metastatic Prostate Cancer (PROfound Study) Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedA new revision entry, v3.6.3, was added to the Study History, superseding the previous v3.6.2. This reflects an update to the record’s versioning rather than a change to study results or eligibility.SummaryDifference0.1%

- Check16 days agoChange DetectedThe revision history now shows a new revision entry v3.6.2, replacing the previous v3.6.0 in the list of study record versions.SummaryDifference0.1%

- Check30 days agoChange DetectedRecruitment is shown as no longer looking for participants. The record also adds a revision stamp, v3.6.0, indicating an updated protocol/document.SummaryDifference0.2%

- Check37 days agoChange DetectedThe revision history now shows a new latest revision (v3.5.5) replacing v3.5.4, indicating a metadata update to the record. No study data or results appear to be altered by this revision.SummaryDifference0.1%

- Check58 days agoChange DetectedA new Revision: v3.5.4 entry was added to the study record history. The previous Revision: v3.5.3 entry was removed from the history.SummaryDifference0.1%

- Check80 days agoChange DetectedThe page now displays an updated ClinicalTrials.gov interface/revision identifier (from v3.5.2 to v3.5.3) without indicating any changes to the underlying study record details.SummaryDifference0.1%

Stay in the know with updates to Olaparib in Metastatic Prostate Cancer (PROfound Study) Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Olaparib in Metastatic Prostate Cancer (PROfound Study) Clinical Trial page.